Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Venous Thromboembolism 7 Venous Thrombosis 5 Pulmonary Embolism 4 Neoplasms 4 Thromboembolism 2 Lung Neoplasms 2 Thrombosis 1 Thrombocytopenia 1 Pancreatic Neoplasms 1 Multiple Myeloma 1 Lymphoma 1 Liver Neoplasms 1 Kidney Neoplasms 1 Hemorrhage 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1

Interventions

Fluorouracil 218 Leucovorin 201 Oxaliplatin 191 Irinotecan 148 Bevacizumab 107 Capecitabine 93 Cetuximab 89 Folfox protocol 54 Chemotherapy, Adjuvant 34 Panitumumab 30 pembrolizumab 23 Nivolumab 22 Colonoscopy 22 Gemcitabine 20 Magnetic Resonance Spectroscopy 19 Floxuridine 19 IFL protocol 18 Celecoxib 18 Radiotherapy 17 Neoadjuvant Therapy 17 Early Intervention, Educational 17 Drug Therapy 17 Laparoscopy 14 Cyclophosphamide 14 Counseling 14 trifluridine tipiracil drug combination 13 regorafenib 13 XELOX 13 Exercise 13 Erlotinib Hydrochloride 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Colonic Neoplasms × Tinzaparin × Clear all

NCT01455831 2021-05-17

PERIOP-01

Ottawa Hospital Research Institute

Phase 3 Completed

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡